Found: 13
Select item for more details and to access through your institution.
Short-Term Safety and Tolerability of Double-Dose Salmeterol/Fluticasone Propionate in Adult Asthmatic Patients.
- Published in:
- Clinical Drug Investigation, 2005, v. 25, n. 4, p. 231, doi. 10.2165/00044011-200525040-00002
- By:
- Publication type:
- Article
Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskus™ or Pressurised Metered-Dose Inhaler in Children with Asthma.
- Published in:
- Clinical Drug Investigation, 2005, v. 25, n. 1, p. 1, doi. 10.2165/00044011-200525010-00001
- By:
- Publication type:
- Article
A Randomized Phase I Study of the Anti‐Interleukin‐33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 565, doi. 10.1002/cpt.3147
- By:
- Publication type:
- Article
Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: Findings from a Phase IIa study.
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 1, p. 21, doi. 10.3109/14397595.2014.896448
- By:
- Publication type:
- Article
P3‐100: CH 1,2, AND 3 BASAL FOREBRAIN NUCLEI VOLUMES PREDICT FUNCTIONAL SENSITIVITY TO MUSCARINIC M1 RECEPTOR ANTAGONIST BIPERIDEN ON DELAYED WORD RECALL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P968, doi. 10.1016/j.jalz.2019.06.3127
- By:
- Publication type:
- Article
Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 3, p. 253, doi. 10.1007/s10637-008-9182-8
- By:
- Publication type:
- Article
Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 175, doi. 10.1093/rheumatology/kex383
- By:
- Publication type:
- Article
A phase 1b/2amulticenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M<sub>1</sub> receptor agonist HTL0018318 in patients with mild-to-moderate Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022, v. 8, n. 1, p. 1, doi. 10.1002/trc2.12273
- By:
- Publication type:
- Article
Mavrilimumab, a Fully Human Granulocyte–Macrophage Colony‐Stimulating Factor Receptor α Monoclonal Antibody.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 5, p. 679, doi. 10.1002/art.40420
- By:
- Publication type:
- Article
A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 1, p. 49, doi. 10.1002/art.40323
- By:
- Publication type:
- Article
Vandetanib with FOLFIRI in patients with advanced colorectal adenocarcinoma: results from an open-label, multicentre Phase I study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 4, p. 665, doi. 10.1007/s00280-008-0914-4
- By:
- Publication type:
- Article
Pharmacodynamic biomarkers and differential effects of TNF‐ and GM‐CSF‐targeting biologics in rheumatoid arthritis.
- Published in:
- International Journal of Rheumatic Diseases, 2019, v. 22, n. 4, p. 646, doi. 10.1111/1756-185X.13395
- By:
- Publication type:
- Article
A novel somatostatin receptor ligand for human ACTH – and GH –secreting pituitary adenomas.
- Published in:
- European Journal of Endocrinology, 2024, v. 190, n. 1, p. K8, doi. 10.1093/ejendo/lvad171
- By:
- Publication type:
- Article